very much looking forward to BTX 1204 Atopic Dermatitis Ph2 Results Q1 2020
supply line improvements in place for this study will be representative of supply for the proposed BTX 1503 Ph3.
positive (statistically significant) results will see confidence return across the board, and reinforce BTX 1503 credibility
very much looking forward to BTX 1204 Atopic Dermatitis Ph2...
-
- There are more pages in this discussion • 93 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
39.0¢ |
Change
0.010(2.63%) |
Mkt cap ! $696.8M | |||
| Open | High | Low | Value | Volume |
| 38.0¢ | 39.0¢ | 37.5¢ | $1.405M | 3.664M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 10 | 148434 | 38.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 39.0¢ | 809785 | 20 |
View Market Depth
| Last trade - 13.55pm 01/08/2024 (20 minute delay) ? |
| BOT (ASX) Chart |